Resultados de la búsqueda 631-640 of 2335 for Lupus

  1. Oncología (médica) - Ensayos clínicos

    This proposal will begin intense lymphedema screening and identify baseline characteristics potentially predisposing someone to lymphedema, and identify ...

  2. Ensayos clínicos - Neurología

    The purpose of this study is to learn more about the distribution of the pathological protein tau in the living brains of patients with Progressive Supranuclear ...

  3. Mayo Clinic

    Share · Tweet . IMG-20451390. Inicio; cc-confident-woman-business_tablet. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the effects of ibrutinib and rituximab with or without venetoclax in treating patients with previously untreated ...

  5. Cansancio Responden los expertos - Mayo Clinic

    Vivir con lupus · Síndrome del intervalo QT largo · Recuento bajo de células ... Dieta baja en fósforo: ¿es útil para la enfermedad renal? Lupus · Enfermedad ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Molecular characterization may include short tandem DNA repeat; STR) and oncogenic/tumor suppressor gene mutation analyses to assure that the derived models ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Guidance for molecular targeted therapy will involve gene analysis of oncogenes and tumor suppressor genes. Results from these studies may provide the rationale ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...

  10. Ensayos clínicos - Neurología

    The purpose of this study is to learn more about the distribution of the pathological protein tau in the living brains of patients with Progressive Supranuclear ...